NCT01090791

Brief Summary

Acute circulatory failure may be related to hypovolemia. Fluid loading increases stroke volume in approximatively half of challenges. Determining fluid responsiveness prevents unnecessary fluid loading. Passive leg raising (PLR) provides a transient increase of 300 ml in venous return for a short time. The measurement of stroke volume (SV) before and after a PLR test allows physician to detect fluid responsiveness, when stroke volume increases is higher than 15 %. Beside thermodilution, the use of non invasive device to measure stroke volume becomes largely employed. Arterial Pressure based Cardiac Output (APCO), provided by the Flotrac/Vigileo system, does not required specific materials nor repeated calibration. The third generation software is believed to be more accurate and more precise for SV measurement. The aim of this study is to test the performance of the Flotrac/Vigileo device in a situation of rapid venous return changes induced by PLR and then by fluid loading. Patients will be classify posteriorly in responders and non responders, according to the magnitude of the fluid loading-induced SV changes measured by transthoracic echocardiography.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2011

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 22, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 23, 2010

Completed
1.1 years until next milestone

Study Start

First participant enrolled

May 1, 2011

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2016

Completed
Last Updated

September 8, 2016

Status Verified

September 1, 2016

Enrollment Period

5.3 years

First QC Date

March 22, 2010

Last Update Submit

September 7, 2016

Conditions

Keywords

critically ill patient

Outcome Measures

Primary Outcomes (1)

  • Stroke volume measurement between Flotrac/Vigileo device and transthoracic echocardiography

    Bland-Altman analysis of the whole SV measurements

    30 min

Secondary Outcomes (2)

  • SV cut-off with Flotrac/Vigileo and with TEE to predict fluid responsiveness

    30 min

  • SVV cut-off with Flotrac/Vigileo to predict fluid responsiveness

    30 min

Interventions

Measurement of stroke volume according to the arterial pressure waveform

Measurement of stroke volume according to the aortic time-velocity integral

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Critically ill patients with acute circulatory failure, as defined by two or more of the inclusion criteria.

You may qualify if:

  • Systolic arterial pressure \< 90 mmHg or Mean arterial pressure \< 60 mmHg
  • Heart rate \> 100 bpm
  • Norepinephrine infusion
  • Urine output \< 0.5 ml/kg/h during at least two consecutive hours
  • skin mottling
  • Capillary refill time \> 3 sec

You may not qualify if:

  • Acute cor pulmonale
  • Ongoing renal replacement therapy
  • Lack of echogenicity during transthoracic echocardiography

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hopital Paul Desbief

Marseille, 13002, France

Location

Hopital Ambroise Paré

Marseille, 13006, France

Location

MeSH Terms

Conditions

Critical IllnessShock

Interventions

Echocardiography

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Cardiac Imaging TechniquesDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisUltrasonographyHeart Function TestsDiagnostic Techniques, Cardiovascular

Study Officials

  • Jérôme Allardet-Servent, MD,MSc

    Fondation Hôpital Ambroise Paré

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, MSc

Study Record Dates

First Submitted

March 22, 2010

First Posted

March 23, 2010

Study Start

May 1, 2011

Primary Completion

September 1, 2016

Study Completion

September 1, 2016

Last Updated

September 8, 2016

Record last verified: 2016-09

Locations